TY - JOUR
T1 - Association of Sedentary Lifestyle with Risk of Acute and Post-Acute COVID-19 Sequelae
T2 - A Retrospective Cohort Study
AU - Zheng, Chen
AU - Huang, Wendy Ya-Jun
AU - Sun, Feng-Hua
AU - Wong, Martin Chi-Sang
AU - Siu, Parco Ming-Fai
AU - Chen, Xiang-Ke
AU - Wong, Stephen Heung-Sang
N1 - Copyright © 2023. Published by Elsevier Inc.
PY - 2023/12/17
Y1 - 2023/12/17
N2 - Background: Evidence suggests that coronavirus disease 2019
(COVID-19) survivors could experience COVID-19 sequelae. Although various risk
factors for COVID-19 sequelae have been identified, little is known about
whether a sedentary lifestyle is an independent risk factor.
Methods: In this retrospective cohort study, 4,850
participants self-reported their COVID-19 sequelae symptoms between June and
August 2022. A sedentary lifestyle, including physical inactivity (<150
min/week of moderate-to-vigorous intensity physical activity) and prolonged
sedentary behavior (≥10 h/day), before the fifth COVID-19 wave was recorded.
Logistic regression analysis was performed to determine the relationships
between sedentary lifestyle and risk of acute and post-acute (lasting ≥2
months) COVID-19 sequelae.
Results: A total of 1,443 COVID-19 survivors and 2,962
non-COVID-19 controls were included. Of the COVID-19 survivors, >80% and
>40% self-reported acute and post-acute COVID-19 sequelae, respectively. In
the post-acute phase, COVID-19 survivors who were physically inactive had a 37%
lower risk of insomnia, whereas those with prolonged sedentary behavior had
25%, 67%, and 117% higher risks of at least one symptom, dizziness, and “pins
and needles” sensation, respectively. For the acute phase, prolonged sedentary
behavior was associated with a higher risk of fatigue, “brain fog”, dyspnea,
muscle pain, joint pain, dizziness, and “pins and needles” sensation. Notably,
sedentary behavior, rather than physical inactivity, was correlated with a
higher risk of severe post-COVID-19 sequelae in both acute and post-acute
phases.
Conclusions: Prolonged sedentary behavior was independently
associated with a higher risk of both acute and post-acute COVID-19 sequelae,
whereas physical inactivity played contradictory roles in COVID-19 sequelae.
AB - Background: Evidence suggests that coronavirus disease 2019
(COVID-19) survivors could experience COVID-19 sequelae. Although various risk
factors for COVID-19 sequelae have been identified, little is known about
whether a sedentary lifestyle is an independent risk factor.
Methods: In this retrospective cohort study, 4,850
participants self-reported their COVID-19 sequelae symptoms between June and
August 2022. A sedentary lifestyle, including physical inactivity (<150
min/week of moderate-to-vigorous intensity physical activity) and prolonged
sedentary behavior (≥10 h/day), before the fifth COVID-19 wave was recorded.
Logistic regression analysis was performed to determine the relationships
between sedentary lifestyle and risk of acute and post-acute (lasting ≥2
months) COVID-19 sequelae.
Results: A total of 1,443 COVID-19 survivors and 2,962
non-COVID-19 controls were included. Of the COVID-19 survivors, >80% and
>40% self-reported acute and post-acute COVID-19 sequelae, respectively. In
the post-acute phase, COVID-19 survivors who were physically inactive had a 37%
lower risk of insomnia, whereas those with prolonged sedentary behavior had
25%, 67%, and 117% higher risks of at least one symptom, dizziness, and “pins
and needles” sensation, respectively. For the acute phase, prolonged sedentary
behavior was associated with a higher risk of fatigue, “brain fog”, dyspnea,
muscle pain, joint pain, dizziness, and “pins and needles” sensation. Notably,
sedentary behavior, rather than physical inactivity, was correlated with a
higher risk of severe post-COVID-19 sequelae in both acute and post-acute
phases.
Conclusions: Prolonged sedentary behavior was independently
associated with a higher risk of both acute and post-acute COVID-19 sequelae,
whereas physical inactivity played contradictory roles in COVID-19 sequelae.
U2 - 10.1016/j.amjmed.2023.12.002
DO - 10.1016/j.amjmed.2023.12.002
M3 - Journal article
C2 - 38110069
SN - 0002-9343
JO - American Journal of Medicine
JF - American Journal of Medicine
ER -